This $159,811 federal Project Grant awarded on May 1, 2024 by the Defense Health Agency supports research at the University of Illinois to investigate the role of SOX4 in phenotypic transformation from non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) in order to overcome acquired drug resistance. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The University of Illinois research aims to advance the understanding of cancer progression and drug resistance, with the goal of informing more effective lung cancer treatments for military populations and the general public.
Generated 12/10/24, 10:24 AM